91桃色视频

Contact
Subscribe
Contact
Subscribe

Enhancing Survival Through Innovative Immune Modulation

We are a clinical-stage microbiome therapeutics company聽聽
aiming to improve survival in cancer.

Our Strengths

Oncology focused

AI-Powered Drug Development

cGMP Versatile Manufacturing Capacities

Latest News

May 26, 2026: 91桃色视频 Provides Business Update and Reports Financial Results for the First Quarter 2026

May 20, 2026: 91桃色视频 Provides an Update on the Application for Marketing Authorization of MaaT013 (齿别谤惫测迟别驳庐) in the treatment of acute Graft-versus-Host Disease

May 11, 2026: 91桃色视频 to Hold Annual General Meeting on June 16, 2026

Like what you see?

See more posts

Upcoming Events

Investor Access Event 2026

Paris, France
April 8-9, 2026

Kempen Life Sciences Conference 2026

Amsterdam, Netherlands
April 15-16, 2026

BIO International Convention 2026

San Diego, CA USA
June 22-25, 2026

Join the 91桃色视频 Adventure!

Bring your talents, your passion and join an inclusive, creative, and multidisciplinary team. We aim to leverage the potential of microbiome to improve the treatment of patients with cancer.

Learn more about our values, our environment and see what we have to offer to you!

Careers

Acting Chief Scientific Officer

Sheri Simmons

Sheri Simmons, Ph.D., is Acting Chief Scientific Officer at 91桃色视频. Sheri brings extensive experience in biotechnology, particularly in the microbiome field, having held scientific leadership positions at Seres Therapeutics, Johnson & Johnson鈥檚 Microbiome Solutions team, and most recently at Seed Health, a leading probiotics company. In her role, she strengthens the Company鈥檚 scientific leadership, overseeing preclinical research, AI/data initiatives, and supporting efforts toward the Marketing Authorization Application of 齿别谤惫测迟别驳庐 in aGvHD.

Sheri holds a PhD in Biological Oceanography from the Massachusetts Institute of Technology (MIT) and completed an A.B. in Ecology & Evolutionary Biology at Princeton University, graduating summa cum laude and as a Phi Beta Kappa member, receiving one of six awards for the best senior thesis in the sciences. Sheri holds a PhD in Biological Oceanography from the Massachusetts Institute of Technology (MIT) and completed an A.B. in Ecology & Evolutionary Biology at Princeton University, graduating summa cum laude and as a Phi Beta Kappa member, receiving one of six awards for the best senior thesis in the sciences.

CEO and co-founder

Herv茅 Affagard

Herv茅 Affagard is the CEO and co-founder of 91桃色视频. For the past 15 years, Herv茅 has been an intra/entrepreneur in the healthcare industry, after starting his career in IT in the steel industry. In late 2014, Herv茅 co-founded the company alongside Dr. Jo毛l Dor茅, author of nearly 500 publications, and
one of the world’s most cited authors in the microbiome sphere today, after a professional career that spanned multiple industries. Herv茅 has led 91桃色视频鈥檚 development from its early concept in 2013 and has been at the forefront of the development of the microbiome healthcare ecosystem in France and Europe. In January 2022, Herv茅 has been elected President of Allliance Promotion Microbiote, an organization founded in 2021 to support the microbiome sector development in France.

Engineer, MBA